Titre : Mobilité réduite

Mobilité réduite : Questions médicales fréquentes

Termes MeSH sélectionnés :

Minimal Clinically Important Difference
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Mobilité réduite : Questions médicales les plus fréquentes", "headline": "Mobilité réduite : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Mobilité réduite : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-01", "dateModified": "2025-02-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Mobilité réduite" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Signes et symptômes", "url": "https://questionsmedicales.fr/mesh/D012816", "about": { "@type": "MedicalCondition", "name": "Signes et symptômes", "code": { "@type": "MedicalCode", "code": "D012816", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888" } } }, "about": { "@type": "MedicalCondition", "name": "Mobilité réduite", "alternateName": "Mobility Limitation", "code": { "@type": "MedicalCode", "code": "D051346", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Marco Pahor", "url": "https://questionsmedicales.fr/author/Marco%20Pahor", "affiliation": { "@type": "Organization", "name": "University of Florida, Gainesville, FL, 32611, USA." } }, { "@type": "Person", "name": "Suzanne G Leveille", "url": "https://questionsmedicales.fr/author/Suzanne%20G%20Leveille", "affiliation": { "@type": "Organization", "name": "College of Nursing and Health Sciences, University of Massachusetts, Boston, MA, USA." } }, { "@type": "Person", "name": "Jonathan F Bean", "url": "https://questionsmedicales.fr/author/Jonathan%20F%20Bean", "affiliation": { "@type": "Organization", "name": "New England Geriatric Research Education and Clinical Center, Boston Veterans Administration Health System, Boston, MA, USA; Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA." } }, { "@type": "Person", "name": "Samuel Poncé", "url": "https://questionsmedicales.fr/author/Samuel%20Ponc%C3%A9", "affiliation": { "@type": "Organization", "name": "Department of Materials, University of Oxford, Parks Road, Oxford OX1 3PH, U.K." } }, { "@type": "Person", "name": "Feliciano Giustino", "url": "https://questionsmedicales.fr/author/Feliciano%20Giustino", "affiliation": { "@type": "Organization", "name": "Department of Materials, University of Oxford, Parks Road, Oxford OX1 3PH, U.K." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The anchor design of anchor-based method to determine the minimal clinically important difference: a systematic review.", "datePublished": "2023-07-15", "url": "https://questionsmedicales.fr/article/37454099", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12955-023-02157-3" } }, { "@type": "ScholarlyArticle", "name": "Risk factors for failure to achieve minimal clinically important difference following cervical disc replacement.", "datePublished": "2023-09-01", "url": "https://questionsmedicales.fr/article/37660897", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.spinee.2023.08.017" } }, { "@type": "ScholarlyArticle", "name": "Establishing the minimal clinically important difference of the EQ-5D-3L in older adults with a history of falls.", "datePublished": "2022-08-23", "url": "https://questionsmedicales.fr/article/35999431", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11136-022-03231-x" } }, { "@type": "ScholarlyArticle", "name": "Defining Minimal Clinically Important Difference and Patient Acceptable Symptom State After the Latarjet Procedure.", "datePublished": "2022-07-18", "url": "https://questionsmedicales.fr/article/35850119", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/03635465221107939" } }, { "@type": "ScholarlyArticle", "name": "Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency.", "datePublished": "2022-11-02", "url": "https://questionsmedicales.fr/article/36332897", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cardfail.2022.10.423" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Mobilité réduite", "item": "https://questionsmedicales.fr/mesh/D051346" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Mobilité réduite - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Mobilité réduite", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Mobilité réduite", "description": "Comment diagnostiquer une mobilité réduite ?\nQuels tests sont utilisés pour évaluer la mobilité ?\nQuels professionnels évaluent la mobilité ?\nQuels signes cliniques indiquent une mobilité réduite ?\nLa mobilité réduite est-elle toujours permanente ?", "url": "https://questionsmedicales.fr/mesh/D051346?mesh_terms=Minimal+Clinically+Important+Difference&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Mobilité réduite", "description": "Quels sont les symptômes de la mobilité réduite ?\nLa douleur affecte-t-elle la mobilité ?\nComment la fatigue influence-t-elle la mobilité ?\nLes troubles de l'équilibre sont-ils liés à la mobilité réduite ?\nLes changements d'humeur affectent-ils la mobilité ?", "url": "https://questionsmedicales.fr/mesh/D051346?mesh_terms=Minimal+Clinically+Important+Difference&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Mobilité réduite", "description": "Comment prévenir la mobilité réduite ?\nLes exercices de renforcement sont-ils bénéfiques ?\nL'évaluation régulière de la santé est-elle importante ?\nComment l'environnement influence-t-il la mobilité ?\nLes programmes communautaires aident-ils à prévenir ?", "url": "https://questionsmedicales.fr/mesh/D051346?mesh_terms=Minimal+Clinically+Important+Difference&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Mobilité réduite", "description": "Quels traitements sont disponibles pour la mobilité réduite ?\nLa chirurgie peut-elle aider la mobilité ?\nLes médicaments sont-ils efficaces pour la mobilité ?\nComment la réhabilitation aide-t-elle ?\nLes aides techniques sont-elles utiles ?", "url": "https://questionsmedicales.fr/mesh/D051346?mesh_terms=Minimal+Clinically+Important+Difference&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Mobilité réduite", "description": "Quelles complications peuvent survenir avec la mobilité réduite ?\nLa mobilité réduite augmente-t-elle le risque de maladies ?\nComment la mobilité réduite affecte-t-elle la qualité de vie ?\nLes complications respiratoires sont-elles possibles ?\nLa mobilité réduite peut-elle entraîner des problèmes musculaires ?", "url": "https://questionsmedicales.fr/mesh/D051346?mesh_terms=Minimal+Clinically+Important+Difference&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Mobilité réduite", "description": "Quels sont les facteurs de risque de mobilité réduite ?\nLe surpoids influence-t-il la mobilité ?\nLes troubles neurologiques sont-ils un facteur de risque ?\nL'inactivité physique est-elle un facteur de risque ?\nLes problèmes de vision affectent-ils la mobilité ?", "url": "https://questionsmedicales.fr/mesh/D051346?mesh_terms=Minimal+Clinically+Important+Difference&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une mobilité réduite ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen physique, l'historique médical et des tests fonctionnels." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la mobilité ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme le Timed Up and Go (TUG) et l'évaluation de la marche sont courants." } }, { "@type": "Question", "name": "Quels professionnels évaluent la mobilité ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les médecins, physiothérapeutes et ergothérapeutes sont impliqués dans l'évaluation." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une mobilité réduite ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des signes incluent des difficultés à marcher, des chutes fréquentes et une fatigue accrue." } }, { "@type": "Question", "name": "La mobilité réduite est-elle toujours permanente ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, elle peut être temporaire ou permanente selon la cause sous-jacente." } }, { "@type": "Question", "name": "Quels sont les symptômes de la mobilité réduite ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, fatigue, raideur articulaire et difficulté à se déplacer." } }, { "@type": "Question", "name": "La douleur affecte-t-elle la mobilité ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la douleur peut limiter la capacité à se déplacer et à effectuer des activités quotidiennes." } }, { "@type": "Question", "name": "Comment la fatigue influence-t-elle la mobilité ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "La fatigue peut réduire l'endurance et rendre les déplacements plus difficiles." } }, { "@type": "Question", "name": "Les troubles de l'équilibre sont-ils liés à la mobilité réduite ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les troubles de l'équilibre peuvent contribuer à des chutes et à une mobilité limitée." } }, { "@type": "Question", "name": "Les changements d'humeur affectent-ils la mobilité ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'anxiété et la dépression peuvent aggraver la perception de la mobilité réduite." } }, { "@type": "Question", "name": "Comment prévenir la mobilité réduite ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une activité physique régulière et une alimentation équilibrée aide à prévenir." } }, { "@type": "Question", "name": "Les exercices de renforcement sont-ils bénéfiques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils renforcent les muscles et améliorent la stabilité, réduisant le risque de chutes." } }, { "@type": "Question", "name": "L'évaluation régulière de la santé est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des bilans de santé réguliers permettent de détecter précocement des problèmes de mobilité." } }, { "@type": "Question", "name": "Comment l'environnement influence-t-il la mobilité ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement adapté, sans obstacles, facilite les déplacements et réduit les risques de chutes." } }, { "@type": "Question", "name": "Les programmes communautaires aident-ils à prévenir ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des programmes de sensibilisation et d'exercices en groupe favorisent la mobilité." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour la mobilité réduite ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la physiothérapie, les médicaments et les aides à la mobilité." } }, { "@type": "Question", "name": "La chirurgie peut-elle aider la mobilité ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines interventions chirurgicales peuvent améliorer la mobilité en corrigeant des anomalies." } }, { "@type": "Question", "name": "Les médicaments sont-ils efficaces pour la mobilité ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments anti-inflammatoires et analgésiques peuvent soulager la douleur et améliorer la mobilité." } }, { "@type": "Question", "name": "Comment la réhabilitation aide-t-elle ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La réhabilitation physique aide à restaurer la fonction et à améliorer la force musculaire." } }, { "@type": "Question", "name": "Les aides techniques sont-elles utiles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les cannes, déambulateurs et fauteuils roulants peuvent faciliter les déplacements." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la mobilité réduite ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent les chutes, les blessures, et la dépression due à l'isolement." } }, { "@type": "Question", "name": "La mobilité réduite augmente-t-elle le risque de maladies ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut augmenter le risque de maladies cardiovasculaires et de diabète." } }, { "@type": "Question", "name": "Comment la mobilité réduite affecte-t-elle la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut réduire l'autonomie, limiter les interactions sociales et affecter le bien-être mental." } }, { "@type": "Question", "name": "Les complications respiratoires sont-elles possibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'inactivité prolongée peut entraîner des complications respiratoires comme l'atelectasie." } }, { "@type": "Question", "name": "La mobilité réduite peut-elle entraîner des problèmes musculaires ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'inactivité peut provoquer une atrophie musculaire et une faiblesse généralisée." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de mobilité réduite ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge avancé, les maladies chroniques et les blessures antérieures." } }, { "@type": "Question", "name": "Le surpoids influence-t-il la mobilité ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le surpoids peut augmenter la pression sur les articulations et limiter les mouvements." } }, { "@type": "Question", "name": "Les troubles neurologiques sont-ils un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions comme l'AVC ou la sclérose en plaques peuvent affecter la mobilité." } }, { "@type": "Question", "name": "L'inactivité physique est-elle un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'inactivité physique contribue à la faiblesse musculaire et à la perte de mobilité." } }, { "@type": "Question", "name": "Les problèmes de vision affectent-ils la mobilité ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une mauvaise vision peut augmenter le risque de chutes et limiter les déplacements." } } ] } ] }

Sources (10000 au total)

The anchor design of anchor-based method to determine the minimal clinically important difference: a systematic review.

Positive results for clinical outcomes should be not only statistically significant, but also clinically significant. The minimum clinically important difference (MCID) is used to define the minimum t... This study was mainly based on literature research. We performed a systematic search using Web of Science, PubMed, CNKI, Wanfang, and VIP databases. Two reviewers independently screened titles and abs... Three hundred and forty articles were retained for final analysis. For the design of anchors, Subjective anchors (99.12%) were the most common type of anchor used, mainly the Patient's rating of chang... It is of great importance to select several types of anchors and to use more reliable statistical methods to calculate the MCID. It is suggested that the order of selection of anchors should be: objec...

Risk factors for failure to achieve minimal clinically important difference following cervical disc replacement.

While cervical disc replacement (CDR) has been emerging as a reliable and efficacious treatment option for degenerative cervical spine pathology, not all patients undergoing CDR will achieve minimal c... To identify risk factors for failure to achieve MCID in Neck Disability Index (NDI, Visual Analog Scale (VAS) neck and arm following primary 1- or 2-level CDRs in the early and late postoperative peri... Retrospective review of prospectively collected data.... Patients who had undergone primary 1- or 2-level CDR for the treatment of degenerative cervical pathology at a single institution with a minimum follow-up of 6 weeks between 2017 and 2022.... Patient-reported outcomes: Neck disability index (NDI), Visual analog scale (VAS) neck and arm, MCID.... Minimal clinically important difference achievement rates for NDI, VAS-Neck, and VAS-Arm within early (within 3 months) and late (6 months to 2 years) postoperative periods were assessed based on prev... A total of 154 patients met the inclusion criteria. The majority of patients achieved MCID for NDI, VAS-Neck, and VAS-Arm for both early and late postoperative periods-79% achieved MCID for at least o... Our study identified several risk factors for failure to achieve MCID in common PROMs following CDR including predominant neck pain, myelopathy, anxiety, and CDR at levels C5-C7. These findings may he...

Establishing the minimal clinically important difference of the EQ-5D-3L in older adults with a history of falls.

Establish the minimal clinically important difference (MCID) of a health-related quality of life (HRQoL) measure-the EuroQol EQ-5 Dimensions-3 Level (EQ-5D-3L)-in older adults with a history of falls.... This study is a secondary analysis of 255 complete cases who were enrolled in a 12-month randomized controlled trial (NCT01029171; NCT00323596); participants were randomized to the Otago Exercise Prog... EQ-5D-3L MCID ranges for minimal improvements (OEP = 0.028 to 0.059; CON = 0.007 to 0.051), maximal improvements (OEP = 0.059 to 0.090; CON = 0.051 to 0.090), minimal declines (OEP = - 0.029 to - 0.10... Our results will assist in the interpretation of changes in HRQoL, as measured by the EQ-5D-3L, in older adults with a history of falls....

Defining Minimal Clinically Important Difference and Patient Acceptable Symptom State After the Latarjet Procedure.

The Latarjet procedure is one of the most well-established treatment options for anterior shoulder instability. However, meaningful clinical outcomes after this surgery have not been defined.... This study aimed to establish the minimal clinically important difference (MCID) and Patient Acceptable Symptom State (PASS) for commonly used outcome measures in patients undergoing the Latarjet proc... Case series; Level of evidence, 4.... A multicenter retrospective review at 4 institutions was performed to identify patients undergoing primary open Latarjet procedure with minimum 2-year follow-up. Data collected included patient charac... A total of 156 patients were included in the study. The MCID values for ASES, SANE, VAS pain, and WOSI were calculated to be 9.6, 12.4, 1.7, and 254.9, respectively. The PASS values for ASES, SANE, VA... This study defined MCID and PASS values for 4 commonly used outcome measures in patients undergoing the Latarjet procedure. These findings are essential for incorporating patient perspectives into the...

Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency.

The 6-minute walk test (6MWT) is widely used to measure exercise capacity; however, the magnitude of change that is clinically meaningful for individuals is not well established in heart failure with ... To calculate the minimal clinically important difference (MCID) for change in exercise capacity in the 6MWT in iron-deficient populations with HFrEF.... In this pooled secondary analysis of the FAIR-HF and CONFIRM-HF trials, mean changes in the 6MWT from baseline to weeks 12 and 24 were calculated and calibrated against the Patient Global Assessment (... Of 760 patients included in the 2 trials, 6MWT and PGA data were available for 680 (89%) and 656 (86%) patients at weeks 12 and 24, respectively. The mean 6MWT distance at baseline was 281 ± 103 meter... The MCID for improvement in exercise capacity in the 6MWT was 14 meters-15 meters in patients with HFrEF and iron deficiency. These MCIDs can aid clinical interpretation of study data....

The minimal clinically important difference of the mini-balance evaluation systems test in patients with early subacute stroke.

There is insufficient evidence regarding the minimal clinically important difference (MCID) of the Mini-Balance Evaluation Systems Test (Mini-BESTest).... To determine the MCID of the Mini-BESTest in patients with early subacute stroke.... In this prospective cohort study, the Mini-BESTest score of 50 patients with stroke was obtained within 1 week of their admission, their Mini-BESTest and Global Rating of Change Scale (GRCS) scores we... The mean (SD) number of days between evaluations was 15.4 (4.8), and the Mini-BESTest score at admission was 17.7 (5.2) and 23.1 (3.5) at discharge. The correlation between the GRCS and the change in ... The MCID based on the anchor method was 4.2-4.5 points, and the MCID based on the distribution method was 2.3 points....

Establishing the Minimal Clinically Important Difference and Substantial Clinical Benefit for the Pain Visual Analog Scale in a Postoperative Hand Surgery Population.

Although the pain visual analog scale (VAS-pain) is a ubiquitous patient-reported outcome instrument, it remains unclear how to interpret changes or differences in scores. Therefore, our purpose was t... Adult postoperative patients treated by 1 of 5 fellowship-trained orthopedic hand surgeons at a single tertiary academic medical center were identified. Inclusion required VAS-pain scores at baseline ... There were 667 and 148 total patients included in the MCID and SCB analyses, respectively. The 1/2 standard deviation MCID estimate was 1.6, and the anchor-based estimate was 1.9. The anchor-based SCB... We propose MCID values in the range of 1.6 to 1.9 and SCB values in the range of 2.2 to 2.6 for the VAS-pain instrument in a nonshoulder hand and upper extremity postoperative population.... These MCID and SCB estimates may be useful for powering clinical studies and when interpreting VAS-pain score changes or differences reported in the hand surgery literature. These values are to be app...

Patient Acceptable Symptom State, Minimal Clinically Important Difference, and Substantial Clinical Benefit After Arthroscopic Superior Capsular Reconstruction.

Patient Acceptable Symptom State (PASS), minimal clinically important difference (MCID), and substantial clinical benefit (SCB) have rarely been assessed after arthroscopic superior capsular reconstru... (1) To investigate PASS, MCID, and SCB values for pain visual analog scale (pVAS), American Shoulder and Elbow Surgeons (ASES) score, Constant score, and Single Assessment Numeric Evaluation (SANE) af... Cohort study (diagnosis); Level of evidence, 2.... We retrospectively collected data from patients who underwent ASCR between June 2013 and October 2020. A total of 88 patients were included, and anchor questions for deriving PASS, MCID, and SCB value... Based on receiver operating characteristic curves, all 4 scores had acceptable area under the curve values (>0.7) for PASS, MCID, and SCB values. The PASS, MCID, and SCB values were 1.5, 2.5, and 4.5 ... Reliable PASS, MCID, and SCB values were achieved for at least 1 year after ASCR surgery. Poor preoperative score, wide acromiohumeral distance, and dominant side all demonstrated higher ORs for at le...

Responsiveness and minimal clinically important difference of the 6-minute walk distance in patients undergoing colorectal cancer surgery.

This study aimed to clarify the responsiveness and minimal clinically important difference (MCID) of the 6-minute walk distance (6MWD) from before and 1 week after surgery in patients with colorectal ... This retrospective cohort study enrolled 97 patients with primary CRC scheduled for surgery. An anchor-based approach estimated the MCID of the 6MWD, with postoperative physical recovery and EuroQol 5... Of the 97 patients, 72 were included in the analysis. The absolute value of ES and SRM of the 6MWD were 0.69 and 0.91, respectively. The ROC curve indicated that the optimal cut-off values for estimat... From before to 1 week after surgery, the responsiveness of the 6MWD was favorable, and the MCID of the 6MWD was -75 to -60 m in patients with CRC....

The minimal clinically important difference (MCID) of the Olerud Molander Ankle Score (OMAS) in patients with unstable ankle fracture.

The Olerud Molander Ankle Score (OMAS) is a widely used validated Patient Reported Outcome Measure (PROM). For clinical research, it is important to determine the Minimal Clinically Important Differen... Data for this descriptive study were extracted from a prospective randomized controlled trial, the RODEO trial. The Dutch version of the OMAS was completed at 3, 6 and 12-month follow-up and estimated... This cohort included 148 patients. The mean OMAS score in the group with minimal improvement between 3 and 6 months was 15.0 (SD 17.5, 95%CI 9.4-20.6) and between 6 and 12 months 9.5 (SD 17.1, 95% CI ... The calculated MCID in patients following surgery for unstable ankle fractures ranges from 10.5 to 15.0 at 3-6-month follow-up and from 7.5 to 11.4 at 6-12-month follow-up, depending on moment and met...